Lihit Lab.,Inc. (TYO:7975)

Lihit Lab.,Inc. Balance Sheet

Financials in millions JPY. Fiscal year is March - February.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Cash & Equivalents	1,429	728	2,332	1,242	1,077	2,259
Cash & Short-Term Investments	1,429	728	2,332	1,242	1,077	2,259
Cash Growth	8.42%	-68.78%	87.76%	15.32%	-52.32%	25.71%
Receivables	1,421	2,071	1,829	1,729	1,766	1,651
Inventory	2,537	2,708	2,870	2,554	2,839	2,513
Other Current Assets	206	217	174	221	343	126
Total Current Assets	5,593	5,724	7,205	5,746	6,025	6,549
Property, Plant & Equipment	5,821	5,805	4,658	5,810	5,207	5,359
Long-Term Investments	2,228	1,928	1,504	1,505	1,483	1,401
Other Intangible Assets	37	42	43	40	16	18
Long-Term Deferred Tax Assets	1	15	20	15	-	-
Other Long-Term Assets	2	2	2	1	1	2
Total Assets	13,682	13,516	13,432	13,117	12,732	13,329

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Accounts Payable	196	329	315	192	185	481
Accrued Expenses	177	189	175	159	150	118
Short-Term Debt	-	-	-	-	130	253
Current Portion of Long-Term Debt	112	112	242	314	-	-
Current Income Taxes Payable	26	18	143	36	13	107
Other Current Liabilities	372	405	427	379	307	352
Total Current Liabilities	883	1,053	1,302	1,080	785	1,311
Long-Term Debt	114	170	195	437	315	445
Pension & Post-Retirement Benefits	710	696	841	842	904	961
Long-Term Deferred Tax Liabilities	517	403	214	241	224	210
Other Long-Term Liabilities	234	216	244	276	285	293
Total Liabilities	2,458	2,538	2,796	2,876	2,513	3,220

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Common Stock	1,830	1,830	1,830	1,830	1,830	1,830
Additional Paid-In Capital	1,411	1,411	1,411	1,411	1,411	1,411
Retained Earnings	6,602	6,651	6,669	6,342	6,521	6,624
Treasury Stock	-401	-401	-401	-401	-401	-401
Comprehensive Income & Other	1,782	1,487	1,127	1,059	858	645
Shareholders' Equity	11,224	10,978	10,636	10,241	10,219	10,109
Total Liabilities & Equity	13,682	13,516	13,432	13,117	12,732	13,329

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Total Debt	226	282	437	751	445	698
Net Cash (Debt)	1,203	446	1,895	491	632	1,561
Net Cash Growth	15.90%	-76.46%	285.95%	-22.31%	-59.51%	49.23%
Net Cash Per Share	354.61	131.49	558.50	144.71	186.27	460.06
Filing Date Shares Outstanding	3.39	3.39	3.39	3.39	3.39	3.39
Total Common Shares Outstanding	3.39	3.39	3.39	3.39	3.39	3.39
Working Capital	4,710	4,671	5,903	4,666	5,240	5,238
Book Value Per Share	3308.09	3235.52	3134.70	3018.26	3011.51	2979.02
Tangible Book Value	11,187	10,936	10,593	10,201	10,203	10,091
Tangible Book Value Per Share	3297.19	3223.15	3122.03	3006.48	3006.80	2973.71

Data Source: S&P Global Market Intelligence Last updated: Oct 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 7, 2026

Data Sources Report a data error